
On The Line: How and why Canadian health care fell years behind
In this episode of On The Line, BioCanRx President and CEO Stephanie Michaud joins Matt Gurney for a conversation about one of the biggest problems facing Canadian health care: Canada produces world-class medical research, but too often struggles to turn those discoveries into treatments that actually reach Canadian patients.
Stephanie explains why it can take so long for the newest and most promising therapies to make their way into the Canadian health-care system — and why so much science developed by Canadian researchers ultimately ends up being commercialized in the United States. Canada…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.